Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University School of Medicine, Boston, Mass.
Division of Acute Care and Trauma Surgery, Boston Medical Center, Boston University School of Medicine, Boston, Mass.
J Vasc Surg. 2021 Aug;74(2):467-476.e4. doi: 10.1016/j.jvs.2020.12.107. Epub 2021 Feb 4.
Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a potentially life-saving intervention. However, recent reports of associations with limb loss and mortality have called its safety into question. We aimed to evaluate patient and hospital characteristics associated with major amputation and in-hospital mortality among patients undergoing REBOA for trauma.
The National Trauma Data Bank (2015-2017) was queried for patients presenting to trauma centers and treated with REBOA. We included REBOA performed on hospital day 1 in patients who survived 6 or more hours from presentation. Univariable and multivariable analyses evaluated associations with major amputation and in-hospital mortality.
A total of 316 patients underwent REBOA and survived in the acute period after presentation. Overall, mean age was 45 ± 20 years and the majority were male (73%) and White (56%). Most patients presented to level I trauma centers (72%) after blunt injuries (79%) with an average Injury Severity Score (ISS) of 31 ± 15, indicating major trauma. In 15 patients (5%), there were 18 major amputations-7 above knee and 11 below knee. A subgroup of 11 amputations were either traumatic amputations (73%) or mangled limbs requiring amputation within 24 hours (27%). Of the remaining amputations, 71% were associated with ipsilateral vascular or orthopedic lower extremity injuries of serious to severe Abbreviated Injury Scale severity. Comparing patients with amputations with those without amputations, there were no significant differences in patient demographics, comorbidities, or hospital characteristics. During hospitalization, patients requiring amputation more frequently received open peripheral vascular interventions (40% vs 10%; P = .002), underwent similar numbers of endovascular interventions (6.7% vs 4.7%; P = .5), and more often developed compartment syndrome (13% vs 2%; P = .04). Overall, there were 110 deaths (35%). The major amputation prevalence was similar between patients who died vs those who survived (3.6% vs 5.3%; P = .5). In multivariable analysis, prehospital cardiac arrest (odds ratio [OR], 8.47; 95% confidence interval [CI], 1.47-48.66; P = .02), penetrating vs blunt trauma (OR, 5.5; 95% CI, 1.05-28.82; P = .04), decreased Glasgow Coma Scale score (OR, 1.18; 95% CI, 1.05-1.32; P = .01), older age (OR, 1.06; 95% CI, 1.03-1.10; P < .001), and increased Injury Severity Score (OR, 1.05; 95% CI, 1.0-1.1; P = .03) were associated with higher mortality.
The majority of major amputations in patients undergoing REBOA were secondary to the initial traumatic mechanism. Injury type and severity, as well as initial hemodynamic derangements, are associated with mortality after REBOA. Despite concerns about prohibitive limb complications of REBOA, baseline injuries seem to be the primary cause of limb loss, but further prospective analysis is needed.
主动脉腔内球囊阻断复苏(REBOA)是一种潜在的救生干预措施。然而,最近有研究报告称其与肢体丧失和死亡率有关,这使得其安全性受到质疑。我们旨在评估接受 REBOA 治疗的创伤患者中与主要截肢和院内死亡相关的患者和医院特征。
查询 2015-2017 年国家创伤数据库(National Trauma Data Bank),纳入在创伤中心接受 REBOA 治疗并存活 6 小时以上的患者。我们纳入了在入院当天接受 REBOA 治疗的患者。单变量和多变量分析评估了与主要截肢和院内死亡相关的因素。
共有 316 名患者接受 REBOA 治疗并在入院后急性期存活。总体而言,平均年龄为 45±20 岁,大多数为男性(73%)和白人(56%)。大多数患者(72%)因钝性伤(79%)就诊于一级创伤中心,平均损伤严重度评分(ISS)为 31±15,表明为严重创伤。在 15 名患者(5%)中,有 18 例主要截肢-7 例膝上截肢,11 例膝下截肢。亚组中有 11 例截肢为创伤性截肢或需要在 24 小时内截肢的残肢,肢体损毁严重。在其余的截肢中,71%与同侧血管或下肢严重到严重的损伤有关,简明损伤严重程度评分(Abbreviated Injury Scale)严重程度为严重。与无截肢患者相比,需要截肢的患者在患者特征、合并症或医院特征方面无显著差异。在住院期间,需要截肢的患者更频繁地接受开放性外周血管介入治疗(40%比 10%;P=0.002),接受的血管内介入治疗次数相似(6.7%比 4.7%;P=0.5),更常发生筋膜室综合征(13%比 2%;P=0.04)。总的来说,有 110 例死亡(35%)。死亡患者与存活患者的主要截肢发生率相似(3.6%比 5.3%;P=0.5)。多变量分析显示,院前心脏骤停(优势比[OR],8.47;95%置信区间[CI],1.47-48.66;P=0.02)、穿透伤比钝性伤(OR,5.5;95% CI,1.05-28.82;P=0.04)、格拉斯哥昏迷评分(OR,1.18;95% CI,1.05-1.32;P=0.01)降低、年龄较大(OR,1.06;95% CI,1.03-1.10;P<0.001)和损伤严重度评分(OR,1.05;95% CI,1.0-1.1;P=0.03)与死亡率增加相关。
在接受 REBOA 治疗的患者中,大多数主要截肢是初始创伤机制的结果。损伤类型和严重程度以及初始血流动力学紊乱与 REBOA 后死亡率相关。尽管对 REBOA 导致肢体并发症的担忧,但基线损伤似乎是导致肢体丧失的主要原因,但需要进一步的前瞻性分析。